ANAPLASTIC LARGE CELL LYMPHOMA, ALK-NEGATIVE

Clinical trials for ANAPLASTIC LARGE CELL LYMPHOMA, ALK-NEGATIVE explained in plain language.

Never miss a new study

Get alerted when new ANAPLASTIC LARGE CELL LYMPHOMA, ALK-NEGATIVE trials appear

Sign up with your email to follow new studies for ANAPLASTIC LARGE CELL LYMPHOMA, ALK-NEGATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 2

Scientists test 'Supercharged' immune cells against stubborn lymphomas

Disease control Recruiting now

This early-stage study is testing a new version of a cancer treatment called CAR-T cell therapy for people whose lymphomas have returned or not responded to standard treatments. Researchers are using pre-made immune cells from healthy donors, modified to better target a protein (…

Matched conditions: ANAPLASTIC LARGE CELL LYMPHOMA, ALK-NEGATIVE

Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

ANAPLASTIC LARGE CELL LYMPHOMA, ALK-NEGATIVE

Get alerted when new ANAPLASTIC LARGE CELL LYMPHOMA, ALK-NEGATIVE trials appear

Scientists test 'Supercharged' immune cells against stubborn lymphomas